Cefurixime peds dose
| Age Group | Dose | Frequency |
|---|---|---|
| Neonate ≤7 days | 100 mg/kg/24 hr | ÷ Q12 hr |
| Neonate >7 days, <1 kg (8–14 days) | 100 mg/kg/24 hr | ÷ Q12 hr |
| Neonate >7 days, <1 kg (≥15 days) | 150 mg/kg/24 hr | ÷ Q8 hr |
| Neonate >7 days, ≥1 kg | 150 mg/kg/24 hr | ÷ Q8 hr |
| Infant >3 mo / Child — mild/moderate | 75–100 mg/kg/24 hr | ÷ Q8 hr (max 1500 mg/dose) |
| Infant >3 mo / Child — severe | 100–200 mg/kg/24 hr | ÷ Q6–8 hr (max 1500 mg/dose) |
| Indication | Dose | Max |
|---|---|---|
| Pharyngitis / Tonsillitis (suspension) | 20 mg/kg/24 hr ÷ Q12 hr | 500 mg/24 hr |
| Impetigo (suspension) | 30 mg/kg/24 hr ÷ Q12 hr | 1 g/24 hr |
| Otitis media / Sinusitis (suspension) | 30 mg/kg/24 hr ÷ Q12 hr | 1 g/24 hr |
| Otitis media / Sinusitis (tablet) | 250 mg BID | — |
| Lyme disease (suspension) | 30 mg/kg/24 hr ÷ Q12 hr × 14–28 days | 1 g/24 hr |
| Indication | Dose |
|---|---|
| Sinusitis, otitis, pharyngitis, tonsillitis | 250 mg Q12 hr |
| Adult (general) | 250–500 mg BID |